Hong Kong stocks soar | Fosun Pharma Hanlin (02696.HK) rises nearly 4% BILDYOS and TUZEMTY approved for commercialization in Canada

According to the Securities Times APP, Fuhong Hanlin (02696.HK) surged nearly 4%, as of the time of writing, it increased by 3.98% to HK$65.05, with a turnover of HK$10.57 million.